Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: A comparative study with IL-4

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 218-227

  Yu, Cheng Rong ^a   Kirken, Robert A ^b   Grazia Malabarba, M ^a   Young, Howard A ^a   Ortaldo, John R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; MONOCLONAL ANTIBODY CD3; PHOSPHOTRANSFERASE;

ARTICLE; CYTOKINE RELEASE; CYTOTOXICITY; DNA PROTEIN COMPLEX; ENZYME REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GROWTH INHIBITORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TIME FACTORS; TRANS-ACTIVATORS;

EID: 0031831628     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Ortaldo, J. R., and R. B. Herberman. 1984. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 2:359.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
3. Paul, E. W., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
4. Minty, A., P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Gouillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, P. Ferrara, and D. Caput. 1993. Interleukin-13 a new human lymphokine regulating inflammatory and immune response. Nature 362:248.
5. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
6. Zurawki, S. M., F. Vega, Jr., B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 cytokine are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
7. Debinski, W., R. Miner, P. Leland, N. I. Obiri, and R. K. Puri. 1996. Receptor for interleukin (IL) 13 does not interact with IL-4 but receptor for IL-4 interacts with IL-13 on human glioma cells. J. Biol. Chem. 271:22428.
8. Burd, P. R., W. C. Thompson, E. E. Max, and F. E. Mills, 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
9. Punnonen, J., G. Aversa, B. G. Cocks, A. N. J. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J. E. de. Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90:3730.
10. Defrance, T., P. Carayon, G. Billian, J-C. Guillmot, A. Minty, D. Caput, and P. Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179:135.
11. Cocks, B. G., R. de Waal Malefyt, J-P. Galizzi, J. E. de. Vries, and G. Aversa. 1993. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5:657.
12. Aversa, G., J. Punnonen, B. G. Cocks, R. de Waal Malefyt, F. Vega, F. V. Sandra, Jr., S. M. Zyrawski, G. Zurawski, and J. E. de. Vries. 1996. An interleukin 4 (IL-4) mutant inhibits both IL-4 or -13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptor. J. Exp. Med. 178:2213.
13. + Th0, Th1 and Th2 T cell clones and EBE-transformed B cells. Int. Immunol. 7:1405.
14. Murata, T., P. D. Noguchi, and R. K. Puri. 1996. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J. Biol. Chem. 270:30829.
15. Obiri, N. I., W. Debinski, W. J. Leonard, and R. K. Puri. 1995. Receptor for IL-13. J. Biol. Chem. 270:8797.
16. Köhler, I., P. Alliger, A. Minty, D. Caput, P. Ferrara, Höll-Neugebauer, B., G. Rank, and E. P. Rieber. 1994. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL-4 sharing a DNA binding motif with an interferon-(-induced nuclear binding factor. FEBS Lett. 345:187.
17. Lin, J-X., T-S. Migone, M. Tsang, M. Griedman, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motif and common Stat protein in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:231.
18. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell 76:253.
19. Zurawski, S. M., P. Chomara, O. Djosson, C. Bidaud, A. N. J. McKenzie, P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270:13869.
20. Smerz-Bertling, C., and A. Duschi. 1995. Both interleukin 4 and interleukin 13 induce tyrosine. J. Biol. Chem. 270:966.
21. Malabarba, M. G., H. Rui, H. H. J. Deutsch, J. Chung, F. S. Kalthoff, W. L. Farrar, and R. A. Kirken. 1996. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-γ and interleukin-4 receptor-α. Biochem. J. 319:865.
22. Malabarba, M. G., R. A. Kirken, H. Rui, K. Koettnitz, M. Kawamura, J. J. O'Shea, F. S. Kalthoff, and W. L. Farrar. 1995. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL-4) stimulated proliferation and requires a membrane-proximal region of IL-4Rα. J. Biol. Chem. 270:9630.
23. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages on STAT6-deficient mice. J. Immunol. 157:3220.
24. Kotowicz, K., R. E. Callard, K. Friedrich, D. J. Matthews, and N. Klein. 1996. Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. Int. Immunol. 8:1915.
25. Takeshita, T., H. Asso, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Najamura, and K. Sugamura. 1992. Cloning of the gamma chain of the human IL-2 receptor. Science 257:379.
26. Kondo, M., T. Takeshita, N. Ishii, M. Nakamura, S. Watanabe, K-I. Arai, and K. Sugamura. 1993. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874.
27. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z-J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, and T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045.
28. Hilton, D. J., J-G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497.
29. Caput, D., P. Laurent, M. Kaghad, J.-M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 271:16921.
30. Aman, M. J. N. Tayebi, N. I. Obiri, M. S. Modi, and W. J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor a chain. J. Biol. Chem. 271:29265.
31. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1416.
32. Ihle, J. N. 1995. Cytokine receptor signaling. Nature 377:591.
33. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251.
34. Russell, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friendmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, A. S. Goldman, F. C. Schmalstieg, J. N. Ihle, J. J. O'Shea, and W. J. Leonard. 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042.
35. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DMA binding factor by IL-4. Science 262:1265.
36. Hou, J., U. Schindler, W. J. Henzel, T-C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:17014.
37. Ryan, J. J., L. C. McReynolds, A. Keegan, L-H. Wang, E. Garfein, P. Rothman, K. Nelms, and W. E. Paul. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123.
38. Wang, H. Y., W. E. Paul, and A. D. Keegan. 1996. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor a chain. Immunity 4:113.
39. Lai, S. Y., J. Molden, K. D. Liu, J. M. Puck, M. D. White, and M. A. Goldsmith. 1996. Interleukin-4-specific signal transduction events are driven by homotypic interaction of the interleukin-4 receptor a chain. EMBO J. 15:4506.
40. Oakes, S. A., F. Candotti, J. A. Johnston, Y-Q. Chen, J. J. Ryan, N. Taylor, X. Liu, L. Hennighausen, L. D. Notarangelo, W. E. Paul, R. M. Blaese, and J. J. O'Shea. 1996. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605.
41. Taketa, K., T. Tanaka, W. Shi, M. Matsumoto, S-I. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishmoto, and S. Akira. 1996. Essential role of STAT6 on IL-4 signaling. Nature 380:627.
42. Shimoda, K., J. v. Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
43. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313.
44. Patel, B. K. R., L-M. Wang, C-C. Lee, W. G. Taylor, J. H. Pierce, and W. J. LaRochelle. 1996. Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J. Biol. Chem. 271:22175.
45. Timomen, T., J. R. Ortaldo, and R. B. Herberman. 1981. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153:569.
46. Smyth, M. J., and J. R. Ortaldo. 1991. Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J. Immunol. 146:1380.
47. Lozzi, C. B., and B. B. Lozzi. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia. Blood 45:321.
48. Mason, L. H., S. K. Anderson, W. M. Yokoyama, H. R. C. Smith, R. Winkler-Pickett, and J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119.
49. Yu, C-R., J-X. Lin, D. W. Fink, S. Akira, E. T. Bloom, and A. Yamauchi. 1996. Differential utilization of Janus kinase-signal transducer and activator of transcription signal pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-α. J. Immunol. 157:126.
50. Rothman, P., S. C. Li, L. Gorham, F. Alt, and M. Boothby. 1991. Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germ line e transcripts. Mol. Cell. Biol. 11:5551.
51. Wagner, B. J., T. E. Hayes, C. J. Hoban, and B. H. Cochran. 1990. The SIE binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9:4477.
52. Sadowski, H. B., K. Shuai, J. E. Darnell, and M. Z. Giman. 1997. A common nuclear signal transduction pathway activated by growth factor and cytokine receptor. Science 261:1739.
53. Nagler, A., L. L. Lanier, and J. H. Phillips. 1988. The effects of IL-4 on human natural killer cells, a potent regulator of IL-2 activation and proliferation. J. Immunol. 141:2349.
54. Kawakami, Y., M. C. Custer, S. A. Rosenberg, and M. T. Lotze. 1989. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. J. Immunol. 142:3452.
55. Vercelli, D., H. H. Jabara, R. P. Lauener, and R. S. Geha. 1990. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte culture. J. Immunol. 144:570.
56. Brown, M., J. Hu-Li, and W. E. Paul. 1988. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism. J. Immunol. 131:504.
57. Martinez, O. M., R. S. Gibbons, M. R. Garvin, and F. R. Aronson. 1990. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J. Immunol. 144:2211.
58. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
59. Zhong, Z., Z. Wen, and J. E. Darnell. 1994. Stat3: STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95.
60. Zhang, X., J. Blenis, H-C. Li, C. Schindler, S. Chen-Kiang. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990.
61. Nakayuki, T., J. Blenis, H-C. Li, C. Schlinder, S. Chen-Kiang. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990.
62. Keegan, A. D., J. A. Johnston, P. J. Tortolani, L. J. McReynolds, C. Kinzer, J. J. O'Shea, and W. E. Paul. 1995. Similarities and differences in signaling transduction by interleukin-4 and interleukin-13: analysis of Janus kinase activation. Proc. Natl. Acad. Sci. USA 92:7681.
63. Rolling, C., D. Treton, S. Pellegrini, P. Galanaud, and Y. Richard. 1996. IL-4 and IL-13 receptors share the gamma chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett. 393:53.
64. Fu, X.-Y., C. Schindler, T. Improta, R. Aebersold, and J. E. Darnell. 1992. The proteins of ISGF-3, the interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA 89:7840.
65. Schaefer, T. S., L. K. Sanders, and D. Nathans. 1995. Cooperative transcriptional activity of Jun and Stat3β, a short form of STAT3. Proc. Natl. Acad. Sci. USA 92:9097.
66. Wang, D., D. Stravopodis, S. Teglund, J. Kitazawa, and J. N. Ihle. 1996. Naturally occurring dominant negative variants of Stat5. Mot. Cell. Biol. 16:6141.
67. Jaso-Friedmann, L., J. H. Leary, III, and D. L. Evans. 1994. Pathways of signaling in nonspecific cytotoxic cells: effects of protein kinase and phosphatase inhibitors and evidence for membrane tyrosine phosphorylation. Cell. Immunol. 153:142.